Search
for
Sort by
Research 271–300 of 1000+
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK Inhibitors for Treatment of Alopecia Areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Immune cell regulation of the hair cycle
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology